Chesapeake Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25
Closed -$7.05K 369
2025
Q3
$7.05K Hold
25
0.01% 250
2025
Q2
$6.98K Sell
25
-8
-24% -$2.27K 0.01% 238
2025
Q1
$10.3K Buy
33
+4
+14% +$1.18K 0.01% 212
2024
Q4
$7.56K Buy
29
+25
+625% +$7.42K 0.01% 232
2024
Q3
$1.29K Sell
4
-332
-99% -$109K ﹤0.01% 294
2024
Q2
$105K Buy
336
+15
+5% +$4.41K 0.1% 95
2024
Q1
$91.3K Sell
321
-290
-47% -$84.9K 0.09% 95
2023
Q4
$176K Buy
611
+455
+292% +$124K 0.16% 90
2023
Q3
$41.9K Hold
156
0.04% 156
2023
Q2
$34.6K Hold
156
0.03% 157
2023
Q1
$37.7K Buy
+156
New +$38.3K 0.03% 159

Other funds holding AMGN

Chesapeake Asset Management's AMGN Position: Q4 2025 in Review

Chesapeake Asset Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 25 shares — an estimated $7.05K sold.

Chesapeake Asset Management first reported a position in AMGN in Q1 2023 and held it in 11 quarters. The position peaked at $176K in Q4 2023. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Chesapeake Asset Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Chesapeake Asset Management sold 25 Amgen shares in Q4 2025, an estimated $7.05K.
  • Chesapeake Asset Management first reported a position in Amgen in Q1 2023 and held it in 11 quarters.
  • Chesapeake Asset Management's Amgen position peaked at $176K in Q4 2023.
  • 3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Chesapeake Asset Management's 13F filing for Q4 2025, filed 8 Jan 2026.